European Journal of Breast Health (Jul 2023)
A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey
- Ibrahim Boga,
- Sebnem Ozemri Sag,
- Nilgun Duman,
- Sevda Yesim Ozdemir,
- Mahmut Cerkez Ergoren,
- Kubilay Dalci,
- Cem Mujde,
- Cem Kaan Parsak,
- Cagla Rencuzogullari,
- Ozge Sonmezler,
- Orcun Yalav,
- Adem Alemdar,
- Lamiya Aliyeva,
- Ozlem Bozkurt,
- Sibel Cetintas,
- Erdem Cubukcu,
- Adem Deligonul,
- Berkcan Dogan,
- Cemre Ornek Erguzeloglu,
- Turkkan Evrensel,
- Sehsuvar Gokgoz,
- Kazim Senol,
- Sahsine Tolunay,
- Esra Akyurek,
- Neslihan Basgoz,
- Nuriye Gökçe,
- Bilge Dundar,
- Figen Ozturk,
- Duygu Taskin,
- Mercan Demirtas,
- Murat Cag,
- Omer Diker,
- Polat Olgun,
- Sevcan Tug Bozdogan,
- Munis Dundar,
- Atil Bisgin,
- Sehime Gulsun Temel
Affiliations
- Ibrahim Boga
- Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey
- Sebnem Ozemri Sag
- Department of Medical Genetics and Genetic Diseases Diagnosis Center, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Nilgun Duman
- Department of Medical Genetics, Bezmialem Vakif University, Dragos Hospital, Istanbul, Turkey
- Sevda Yesim Ozdemir
- Department of Medical Genetics, Uskudar University Faculty of Medicine, Istanbul, Turkey
- Mahmut Cerkez Ergoren
- Department of Medical Genetics, Near East University Faculty of Medicine, Nicosia, Cyprus
- Kubilay Dalci
- Department of General Surgery, Cukurova University Faculty of Medicine, Adana, Turkey
- Cem Mujde
- Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey
- Cem Kaan Parsak
- Department of General Surgery, Cukurova University Faculty of Medicine, Adana, Turkey
- Cagla Rencuzogullari
- Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey
- Ozge Sonmezler
- Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey
- Orcun Yalav
- Department of General Surgery, Cukurova University Faculty of Medicine, Adana, Turkey
- Adem Alemdar
- Department of Translational Medicine, Bursa Uludag University Institute of Health Sciences, Bursa, Turkey
- Lamiya Aliyeva
- Department of Medical Genetics and Genetic Diseases Diagnosis Center, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Ozlem Bozkurt
- Department of Medical Pathology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Sibel Cetintas
- Department of Radiation Oncology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Erdem Cubukcu
- Department of Medical Oncology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Adem Deligonul
- Department of Medical Oncology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Berkcan Dogan
- Department of Medical Genetics and Genetic Diseases Diagnosis Center, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Cemre Ornek Erguzeloglu
- Department of Translational Medicine, Bursa Uludag University Institute of Health Sciences, Bursa, Turkey
- Turkkan Evrensel
- Department of Translational Medicine, Bursa Uludag University Institute of Health Sciences, Bursa, Turkey
- Sehsuvar Gokgoz
- Department of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Kazim Senol
- Department of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Sahsine Tolunay
- Department of Medical Pathology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- Esra Akyurek
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Neslihan Basgoz
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Nuriye Gökçe
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Bilge Dundar
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Figen Ozturk
- Department of Pathology, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Duygu Taskin
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Mercan Demirtas
- Mikrogen Genetic Diagnosis Laboratory, Ankara, Turkey
- Murat Cag
- Department of Vascular Surgery and Transplantation, Strasbourg University Nouvel Hospital, Strasbourg, France
- Omer Diker
- Department of Medical Oncology, Near East University Faculty of Medicine, Nicosia, Cyprus
- Polat Olgun
- Department of Medical Oncology, Near East University Faculty of Medicine, Nicosia, Cyprus
- Sevcan Tug Bozdogan
- Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey
- Munis Dundar
- Department of Medical Genetics, Erciyes University Faculty of Medicine, Kayseri, Turkey
- Atil Bisgin
- Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey
- Sehime Gulsun Temel
- Department of Medical Genetics and Genetic Diseases Diagnosis Center, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
- DOI
- https://doi.org/10.4274/ejbh.galenos.2023.2023-2-5
- Journal volume & issue
-
Vol. 19,
no. 3
pp. 235 – 252
Abstract
Objective:Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2, which are strongly associated with BC, are included in these criteria. The aim of this study was to compare BC index cases with non-BC individuals in terms of genotype and diagnostic features to investigate the genotype/demographic information association.Materials and Methods:Mutational analyses for the BRCA1/BRCA2 genes was performed in 2475 individuals between 2013-2022 from collaborative centers across Turkey, of whom 1444 with BC were designated as index cases.Results:Overall, mutations were identified in 17% (421/2475), while the percentage of mutation carriers in cases of BC was similar, 16.6% (239/1444). BRCA1/BRCA2 gene mutations were detected in 17.8% (131/737) of familial cases and 12% (78/549) of sporadic cases. Mutations in BRCA1 were found in 4.9%, whereas 12% were in BRCA2 (p<0.05). Meta-analyses were performed to compare these results with other studies of Mediterranean-region populations.Conclusion:Patients with BRCA2 mutations were significantly more common than those with BRCA1 mutations. In sporadic cases, there was a lower proportion with BRCA1/BRCA2 variants, as expected, and these results were consistent with the data of Mediterranean-region populations. However, the present study, because of the large sample size, revealed more robust findings than previous studies. These findings may be helpful in facilitating the clinical management of BC for both familial and non-familial cases.
Keywords